We could not exclude the possibility that HTR3C amplification or expression may also be correlated with the response rate to ICB; however, this is the first study to evaluate alterations in the HTR3C gene and protein expression in lung cancer patients. The gene discussed is HTR3C; the disease is lung carcinoma.